Integra Therapeutics, a pioneering biotechnology company at the forefront of gene editing, has successfully raised $10.5 million in a recent funding round aimed at advancing its groundbreaking research. By merging the revolutionary CRISPR technology with the efficiency of viral integrases and transposases, Integra Therapeutics is transforming the landscape of programmable gene delivery. This innovative approach not only allows for precise DNA modification but also enables the introduction of substantial DNA constructs into the genome — a feat that has significant implications for treating genetic disorders and enhancing therapeutic strategies. The funds acquired will be instrumental in accelerating the development of their proprietary technologies, scaling up operations, and expanding their research capabilities. Integra Therapeutics aims to leverage this capital infusion to further integrate advanced genetic engineering techniques into their existing frameworks, ultimately leading to the creation of highly efficient gene therapies that could address a range of previously untreatable genetic conditions. With this recent funding milestone firmly establishing its position in the biotech arena, Integra Therapeutics is poised for rapid growth and innovation, significantly contributing to the evolution of gene therapy and providing hope to patients worldwide.
Integra Therapeutics Secures $10.5 Million in Funding for Cutting-Edge Gene Delivery Technology
Recently funded · €10.5MHealthcare
Get the full Integra Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
